ArticleTherapeutic advances in gastroenterology2024

Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn's disease.

Tong Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.